Table 1.
Clinicopathological characteristics of the enrolled patient
Clinical parameter | |
---|---|
Gender | |
Male | 19 (55.9%) |
Female | 15 (44.1%) |
Age (mean ± SD, year) | 56.29 ± 12.71 |
Primary or Recurrence | |
Primary | 18 (52.9%) |
Recurrence | 16 (47.1%) |
Multiple Lesions | |
Yes | 11 (32.4%) |
No | 23 (67.6%) |
Tumor Size (mean ± SD, cm) | 19.0 ± 12.7 |
Histology | |
LPS | 15 (44.1%) |
GIST | 14 (41.2%) |
LMS | 4 (11.8%) |
DT | 1 (2.9%) |
Multivisceral Resection | |
Yes | 23 (67.6%) |
No | 11 (32.4%) |
Combined Pancreatic Resection* | |
Yes | 9 (26.5%) |
No | 25 (73.5%) |
Anastomosis Style | |
S-style | 21 (62.8%) |
E-style | 13 (38.2%) |
Operation Time (mean ± SD, min) | 344 ± 121 |
Intraoperative Blood Loss (mean ± SD, ml) | 1294 ± 1342 |
Complication | |
Grade 1–2 | 22 (64.7%) |
Grade 3–5 | 12 (35.3%) |
Delayed Gastric Emptying | |
Yes | 12 (35.3%) |
No | 22 (64.7%) |
Incision Infection | |
Yes | 11 (32.4%) |
No | 23 (67.6%) |
Intraperitoneal Infection | |
Yes | 14 (41.2%) |
No | 20 (58.8%) |
Duodenojejunal anastomotic Fistula | |
Yes | 6 (17.6%) |
No | 28 (82.4%) |
Pancreatic Fistula | |
Yes | 7 (20.6%) |
No | 27 (79.4%) |
Postoperative Massive Hemorrhage | |
Yes | 3 (8.8%) |
No | 31 (91.2%) |
Re-operation | |
Yes | 3 (8.8%) |
No | 31 (91.2%) |
Time to Feed (mean ± SD, day) | 18.8 ± 20.1 |
Postoperative Hospital stay (mean ± SD, day) | 27.0 ± 20.2 |
LPS: liposarcoma; LMS: leiomyosarcoma; GIST: gastrointestinal stromal tumor; DT: desmoid tumor; SD: stand deviation
*Refers to the removal of the uncinate or the body and tail of the pancreas